
Nightingale Health
A blood testing company bringing extensive biological data to routine healthcare.
HQ location
Helsinki, Finland
Website
Launch date
Employees
Market cap
$174m
Enterprise value
$110m
Share price
€2.62 HEALTH.HE
Company register number
1750524-0
Recent deals
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
€8.8m | Angel | ||
Total Funding | 000k |
EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 15 % | - | 81 % | 4 % | 8 % | 58 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (181 %) | (394 %) | (278 %) | (211 %) | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (422 %) | (696 %) | (432 %) | (401 %) | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | 15 % | 53 % | 14 % | 5 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nightingale Health
Edit
ACQUISITION by Nightingale Health Jul 2021

ACQUISITION by Nightingale Health Jan 2022

ACQUISITION by Nightingale Health Mar 2024